University of Texas Southwestern Medical Center

Medicine & Life Sciences

1. Neoplasms 100%
2. Therapeutics 87%
3. Proteins 76%
4. Genes 73%
5. Child 63%
6. Pediatrics 61%
7. Wounds and Injuries 54%
8. Mutation 52%
9. Kidney 49%
10. Liver 43%
11. Brain 42%
12. Survival 40%
13. Lung 37%
14. Radiotherapy 35%
15. Growth 34%
16. Population 34%
17. Magnetic Resonance Imaging 34%
18. Mortality 33%
19. Heart 31%
20. T-Lymphocytes 31%
21. Membranes 30%
22. Breast Neoplasms 30%
23. Transplants 30%
24. Infections 30%
25. Heart Failure 30%
26. Enzymes 29%
27. DNA 29%
28. In Vitro Techniques 29%
29. Depression 29%
30. Gene Expression 28%
31. Phenotype 28%
32. Cholesterol 27%
33. Muscles 27%
34. Non-Small Cell Lung Carcinoma 26%
35. Placebos 26%
36. Pharmaceutical Preparations 26%
37. Skin 26%
38. Safety 26%
39. Serum 26%
40. Confidence Intervals 25%
41. Guidelines 25%
42. Phosphorylation 25%
43. Neurons 25%
44. Lung Neoplasms 25%
45. Cell Line 25%
46. Messenger RNA 25%
47. Blood Vessels 24%
48. Stroke 24%
49. Drug Therapy 24%
50. Recurrence 24%
51. Glucose 24%
52. Peptides 24%
53. Phosphotransferases 24%
54. Ligands 23%
55. Biomarkers 23%
56. Pregnancy 23%
57. Incidence 23%
58. Insulin 23%
59. Prostatic Neoplasms 23%
60. Antibodies 22%
61. Equipment and Supplies 22%
62. Carcinoma 22%
63. Magnetic Resonance Spectroscopy 22%
64. Radiation 22%
65. Lipids 21%
66. Homeostasis 21%
67. Blood Pressure 21%
68. Randomized Controlled Trials 21%
69. Neoplasm Metastasis 21%
70. Tomography 21%
71. Animals 20%
72. Prostate 20%
73. Calcium 20%
74. Hypertension 20%
75. Obesity 20%
76. Registries 19%
77. Clinical Trials 19%
78. Exercise 19%
79. Odds Ratio 19%
80. Apoptosis 19%
81. Type 2 Diabetes Mellitus 18%
82. Biopsy 18%
83. Epithelial Cells 18%
84. Inflammation 18%
85. Surgeons 18%
86. Transcription Factors 18%
87. Physicians 18%
88. Breast 18%
89. Morbidity 17%
90. Thorax 17%
91. Oxygen 17%
92. Renal Cell Carcinoma 17%
93. Hospital Emergency Service 17%
94. Alzheimer Disease 17%
95. Fibroblasts 17%
96. HIV 17%
97. Eye 17%
98. Myocardial Infarction 16%
99. Costs and Cost Analysis 16%
100. Pathology 16%